This is incorrect to assume increasing the cash stack relates to the exact valuation of a company. This acquisition is what should add value, however it is yet to be seen (risk increased) and this risk reduces the valuation. The acquisition is complex and management appear overconfident ($0.2 million integration costs) that they will integrate into the current business model (end of July), hopefully they are correct.
- Forums
- ASX - By Stock
- CAT
- Ann: Strategic Acquisition & Equity Raise - Investor Presentation
Ann: Strategic Acquisition & Equity Raise - Investor Presentation, page-22
Featured News
Add CAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.57 |
Change
0.030(1.95%) |
Mkt cap ! $407.3M |
Open | High | Low | Value | Volume |
$1.55 | $1.57 | $1.54 | $58.37K | 37.63K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2657 | $1.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.57 | 2212 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2657 | 1.560 |
2 | 3217 | 1.555 |
4 | 6592 | 1.550 |
2 | 1034 | 1.545 |
2 | 8000 | 1.540 |
Price($) | Vol. | No. |
---|---|---|
1.575 | 3327 | 5 |
1.580 | 3110 | 3 |
1.585 | 4663 | 3 |
1.590 | 4744 | 2 |
1.595 | 1600 | 1 |
Last trade - 11.54am 07/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.56 |
  |
Change
0.030 ( 0.71 %) |
|||
Open | High | Low | Volume | ||
$1.54 | $1.57 | $1.54 | 7074 | ||
Last updated 12.41pm 07/05/2024 ? |
Featured News
CAT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online